ApoTech Overview
- Founded
-
2000
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
- Financing Rounds
-
2
ApoTech General Information
Description
Operator of a biotechnology company intended to commercialize powerful, small molecule anti-apoptotic technologies. The company's technology is designed to offer a platform for rescue of damaged cells from premature death regardless of the exact cause of dysfunction. It focuses on neurodegenerative pathologies such as Parkinson's Disease (PD), Multiple Sclerosis (MS), Amyotrophic Lateral Sclerosis (ALS), Chemotherapy-Induced Neuropathy, Cognitive Decline after Circulatory Arrest (Bypass Dementia) and RNA-Virus Associated Apoptosis.
Contact Information
Ownership Status
Out of Business
Financing Status
Formerly PE-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Primary Office
- 4419 West Sevilla Street
- Tampa, FL 33629
- United States
ApoTech Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|